Tetrabenazine Tablet
Product Images NDC 51407-481

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 51407-481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-480-12lb.jpg (51407 480 12lb)

FDA Label Image

51407-481-12lb.jpg (51407 481 12lb)

51407-481-12lb.jpg (51407 481 12lb)
This is a description of a medication called Tetrabenazine in the form of tablets. The package contains 112 tablets, each with a dosage of 25 mg. The medication is only available with a prescription. To access dosage information, see the package insert. The manufacturer is Apotex Inc. located in Toronto, Ontario, Canada. The medication should be kept in a tightly closed container and out of reach of children. The package has a tamper-evident seal, and if the seal is broken, the medication should not be accepted.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
The text describes a graph or chart showing the "Chorea Score Change" over a certain number of weeks in a study. The graph seems to compare the results of a placebo versus a drug called "Tetrabenazine" on the score change. Unfortunately, the quality of the text is very poor and most of it is unreadable or appears as symbols, making it difficult to draw further conclusions.*
FDA Label Image

Figure2.jpg (Figure2)

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.